title: Levalbuterol is not more cost-effective than albuterol for COPD.
authors.forename: Leslie
authors.initials: L
authors.lastname: Hendeles
authors.forename: Abraham
authors.initials: A
authors.lastname: Hartzema
mesh_terms: D000420:Albuterol / Q000191:economics* / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy / Q000191:economics*; D015982:Bias; D001993:Bronchodilator Agents / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis / Q000706:statistics & numerical data; D006760:Hospitalization / Q000191:economics; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy / Q000191:economics*
chemical_list: D001993:Bronchodilator Agents; D000420:Albuterol